US7304150B1
(en)
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
DK1274728T3
(da)
*
|
2000-04-21 |
2008-09-01 |
Amgen Inc |
Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
|
US6900292B2
(en)
*
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
MXPA04003442A
(es)
|
2001-10-11 |
2004-07-08 |
Applied Reseach Systems Ars Ho |
Uso de activadores de gp130 en neuropatia diabetica.
|
US7737260B2
(en)
|
2003-11-13 |
2010-06-15 |
Hanmi Pharm. Co., Ltd |
Protein complex using an immunoglobulin fragment and method for the preparation thereof
|
KR100467750B1
(ko)
*
|
2001-11-29 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
KR100467751B1
(ko)
*
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
US20050176108A1
(en)
|
2003-03-13 |
2005-08-11 |
Young-Min Kim |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
ES2340494T3
(es)
|
2003-04-15 |
2010-06-04 |
Glaxosmithkline Llc |
Mutantes de sustitucion de il-18 humana y sus conjugados.
|
WO2004101740A2
(en)
|
2003-05-06 |
2004-11-25 |
Syntonix Pharmaceuticals, Inc. |
Clotting factor-fc chimeric proteins to treat hemophilia
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
EP3192872A1
(de)
*
|
2003-08-26 |
2017-07-19 |
The Regents of the University of Colorado, a body corporate |
Inhibitoren der serinproteaseaktivität und deren verwendung in verfahren und zusammensetzungen zur behandlung bakterieller infektionen
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
IL159558A0
(en)
*
|
2003-12-24 |
2004-06-01 |
Applied Research Systems |
Use of il-6 in liver injury
|
IL161673A0
(en)
|
2004-04-29 |
2004-09-27 |
Applied Research Systems |
Compositions and methods for therapy of chemotherapy-induced neuropathy
|
IL161672A0
(en)
|
2004-04-29 |
2004-09-27 |
Yeda Res & Dev |
Compositions and methods for therapy of chemotherapy-induced neuropathy
|
CN1984673A
(zh)
|
2004-05-17 |
2007-06-20 |
阿雷斯贸易股份有限公司 |
干扰素水凝胶制剂
|
EA010979B1
(ru)
|
2004-06-01 |
2008-12-30 |
Арес Трейдинг С.А. |
Стабилизированные жидкие препаративные формы интерферона
|
US7670595B2
(en)
*
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
KR100754667B1
(ko)
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Fc 단편 및이를 포함하는 약제학적 조성물
|
WO2006128176A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Nora Llc |
Composite molecules comprising g-csf function
|
CN101184771A
(zh)
*
|
2005-05-26 |
2008-05-21 |
先灵公司 |
干扰素-IgG融合体
|
DK1885753T3
(da)
|
2005-06-03 |
2011-10-03 |
Ares Trading Sa |
Fremstilling af rekombinant II-18-proteiner
|
RS52273B
(en)
|
2005-06-10 |
2012-10-31 |
Ares Trading S.A. |
PROCESS FOR PURIFICATION OF IL-18 BINDING PROTEIN
|
ATE544866T1
(de)
*
|
2005-06-17 |
2012-02-15 |
Baxter Int |
Adamts13-haltige zusammensetzungen mit thrombolytischer wirkung
|
WO2007021129A1
(en)
|
2005-08-16 |
2007-02-22 |
Hanmi Pharmaceutical Co., Ltd. |
A method for the mass production of immunoglobulin fc region deleted initial methionine residues
|
WO2007025991A2
(en)
|
2005-09-01 |
2007-03-08 |
Ares Trading S.A. |
Treatment of optic neuritis
|
KR20080091180A
(ko)
*
|
2005-12-30 |
2008-10-09 |
파마이센시아 코퍼레이션 |
약물-폴리머 컨쥬게이트
|
US7625564B2
(en)
|
2006-01-27 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
|
JP2009537605A
(ja)
|
2006-05-24 |
2009-10-29 |
メルク セローノ ソシエテ アノニム |
多発性硬化症を治療するためのクラドリビン・レジメン
|
WO2008101671A2
(en)
*
|
2007-02-19 |
2008-08-28 |
Apogenix Gmbh |
Il-4 fc fusion proteins
|
BRPI0814465B1
(pt)
|
2007-07-26 |
2021-11-23 |
Novagen Holding Corporation |
Proteína de fusão, dímero, método para produzir uma proteína de fusão, linhagem de célula, usos de uma proteína de fusão e de uma composição farmacêutica e composição farmacêutica
|
EP2853267B1
(de)
|
2007-09-21 |
2016-12-07 |
The Regents of the University of California |
Gezieltes Interferon mit potenten apoptotischen und Antitumorwirkungen
|
AU2008340058A1
(en)
|
2007-12-20 |
2009-07-02 |
Merck Serono S.A. |
PEG-interferon-beta formulations
|
AU2009274738B2
(en)
|
2008-07-23 |
2012-12-13 |
Hanmi Science Co., Ltd. |
A polypeptide complex comprising non-peptidyl polymer having three functional ends
|
CN102405230A
(zh)
|
2009-04-22 |
2012-04-04 |
默克专利有限公司 |
具有修饰的FcRn结合位点的抗体融合蛋白
|
EP3135294B1
(de)
|
2009-08-14 |
2020-06-03 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Verwendung von il-15 zur erhöhung der thymusleistung und zur behandlung von lymphopenie
|
US8765432B2
(en)
|
2009-12-18 |
2014-07-01 |
Oligasis, Llc |
Targeted drug phosphorylcholine polymer conjugates
|
CN102947341B
(zh)
|
2010-01-19 |
2018-07-06 |
哈佛大学校长及研究员协会 |
用于病原体检测和治疗的工程化调理素
|
DE102010010288A1
(de)
|
2010-03-04 |
2011-09-08 |
Wolfgang Poller |
CCN1 zur Prävention und Therapie von entzündlichen Erkrankungen
|
WO2011107590A1
(en)
|
2010-03-04 |
2011-09-09 |
Wolfgang Poller |
Cnn1 (cyr61) for prevention and therapy of inflammatory disease
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
CN103119054B
(zh)
|
2010-03-26 |
2017-01-18 |
达特茅斯大学理事会 |
Vista调节性t细胞介体蛋白、vista结合剂及其用途
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
AR080993A1
(es)
|
2010-04-02 |
2012-05-30 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de interferon beta donde se usa un fragmento de inmunoglobulina
|
CN102260343A
(zh)
*
|
2010-05-25 |
2011-11-30 |
健能隆医药技术(上海)有限公司 |
重组人g-csf二聚体在治疗神经损伤疾病中的用途
|
KR101337797B1
(ko)
*
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
CN102380090A
(zh)
*
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
G-csf二聚体在治疗嗜中性粒细胞减少症中的应用
|
CN103596587B
(zh)
*
|
2010-10-28 |
2016-09-07 |
健康和人类服务部秘书长代表的美利坚合众国政府 |
纤丝病毒融合蛋白及其应用
|
EP2707021B1
(de)
*
|
2011-05-09 |
2024-02-21 |
Minerva Biotechnologies Corporation |
Genetisch manipulierte wachstumsfaktorvarianten
|
US9320777B2
(en)
|
2011-05-13 |
2016-04-26 |
Bolder Biotechnology, Inc. |
Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure
|
KR102103476B1
(ko)
|
2011-06-24 |
2020-04-23 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
|
US9593160B2
(en)
|
2011-07-18 |
2017-03-14 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
US9642917B2
(en)
|
2011-07-25 |
2017-05-09 |
Generon (Shanghai) Corporation, Ltd. |
Use of G-CSF dimer in preparation of medicament for treatment of neurodegenerative diseases
|
US9243049B2
(en)
|
2011-08-09 |
2016-01-26 |
Uab Profarma |
Derivatives of recombinant proteins, homo-multimers of granulocyte colony-stimulating factor and method of preparation thereof
|
CN102344938A
(zh)
*
|
2011-09-16 |
2012-02-08 |
江苏普罗赛生物技术有限公司 |
哺乳动物细胞大规模生产重组可溶性人干细胞因子与免疫球蛋白Fc片段融合蛋白(sSCF-Fc)的实验技术
|
EP3896759A1
(de)
|
2011-10-05 |
2021-10-20 |
OneD Material, Inc. |
Aktivmaterialien aus siliciumnanostrukturen für lithiumionenbatterien und verfahren dafür sowie zusammensetzungen, komponenten und entsprechende elemente damit
|
AU2013208003B2
(en)
|
2012-01-09 |
2017-12-14 |
The Scripps Research Institute |
Ultralong complementarity determining regions and uses thereof
|
EP2802653A4
(de)
|
2012-01-10 |
2015-09-02 |
Univ Colorado Regents |
Zusammensetzungen, verfahren und verwendung für alpha-1-antitrypsin-fusionsmoleküle
|
JP6280031B2
(ja)
|
2012-03-29 |
2018-02-14 |
中外製薬株式会社 |
抗lamp5抗体およびその利用
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
JP6285923B2
(ja)
*
|
2012-06-22 |
2018-02-28 |
トラスティーズ・オブ・ダートマス・カレッジ |
新規VISTA−Igコンストラクト及び自己免疫、アレルギー性及び炎症性障害の処置のためのVISTA−Igの使用
|
WO2014003176A1
(ja)
*
|
2012-06-29 |
2014-01-03 |
旭化成メディカル株式会社 |
プロテインaのbドメイン変異体を含むポリペプチドが結合された担体からなる吸着材
|
DK2880170T3
(en)
*
|
2012-08-02 |
2016-10-24 |
Hoffmann La Roche |
PROCEDURE FOR PREPARING SOLUBLE FcR AS Fc FUSION WITH INERT IMMUNOGLOBULIN Fc REGION AND APPLICATIONS THEREOF
|
JP6388581B2
(ja)
*
|
2012-08-02 |
2018-09-12 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
単量体および多量体分子を生産するための方法およびその使用
|
AU2013312211B2
(en)
|
2012-09-07 |
2018-03-29 |
King's College London |
VISTA modulators for diagnosis and treatment of cancer
|
WO2014089354A1
(en)
|
2012-12-07 |
2014-06-12 |
The Regents Of The University Of California |
Cd138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
|
US9644021B2
(en)
|
2013-01-11 |
2017-05-09 |
The California Institute For Biomedical Research |
Bovine fusion antibodies
|
KR102073748B1
(ko)
|
2013-01-31 |
2020-02-05 |
한미약품 주식회사 |
재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
|
DK2956476T3
(da)
|
2013-02-18 |
2020-02-17 |
Vegenics Pty Ltd |
Ligandbindende molekyler og anvendelser deraf
|
US20160017017A1
(en)
|
2013-03-11 |
2016-01-21 |
Novo Nordisk Healthcare Ag |
Growth Hormone Compounds
|
US10551379B2
(en)
|
2013-03-15 |
2020-02-04 |
President And Fellows Of Harvard College |
Methods and compositions for improving detection and/or capture of a target entity
|
EP2994758B1
(de)
|
2013-05-08 |
2017-12-20 |
Opthea Limited |
Biomarker für altersbedingte makuladegeneration (amd)
|
JP6649250B2
(ja)
|
2013-05-21 |
2020-02-19 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
操作されたヘム結合性構成物およびその使用
|
WO2014194100A1
(en)
|
2013-05-29 |
2014-12-04 |
The Regents Of The University Of California |
Anti-cspg4 fusions with interferon for the treatment of malignancy
|
AR096891A1
(es)
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo
|
SI3041513T1
(sl)
|
2013-09-08 |
2020-11-30 |
Kodiak Sciences Inc. |
Zwitterionski polimerni konjugati faktorja VIII
|
LT6161B
(lt)
*
|
2013-09-27 |
2015-06-25 |
Uab Profarma |
Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas
|
US10513546B2
(en)
|
2013-12-18 |
2019-12-24 |
President And Fellows Of Harvard College |
CRP capture/detection of gram positive bacteria
|
EP3087098B1
(de)
|
2013-12-24 |
2020-04-08 |
Janssen Pharmaceutica NV |
Anti-vista-antikörper und -fragmente
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
CN106661128A
(zh)
*
|
2014-06-06 |
2017-05-10 |
加州生物医学研究所 |
构建氨基末端免疫球蛋白融合蛋白的方法及其组合物
|
CN107073109B
(zh)
|
2014-06-11 |
2021-08-06 |
凯西·A·格林 |
Vista激动剂和拮抗剂抑制或增强体液免疫的用途
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
WO2016061562A2
(en)
|
2014-10-17 |
2016-04-21 |
Kodiak Sciences Inc. |
Butyrylcholinesterase zwitterionic polymer conjugates
|
EP3226900A4
(de)
|
2014-12-05 |
2018-09-19 |
Immunext, Inc. |
Identifizierung von vsig8 als vermeintlicher vista-rezeptor und dessen verwendung zur herstellung von vista/vsig8-modulatoren
|
JP6621478B2
(ja)
*
|
2014-12-19 |
2019-12-18 |
アルカーメス,インコーポレイテッド |
一本鎖Fc融合タンパク質
|
KR101838919B1
(ko)
*
|
2015-03-03 |
2018-03-15 |
에이비온 주식회사 |
인간 인터페론-베타 변이체가 접합된 면역사이토카인 및 이의 제조방법
|
ES2784603T3
(es)
|
2015-06-02 |
2020-09-29 |
Novo Nordisk As |
Insulinas con extensiones recombinantes polares
|
WO2016207717A1
(en)
|
2015-06-24 |
2016-12-29 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
US10435457B2
(en)
|
2015-08-06 |
2019-10-08 |
President And Fellows Of Harvard College |
Microbe-binding molecules and uses thereof
|
US11229683B2
(en)
|
2015-09-18 |
2022-01-25 |
Bolder Biotechnology, Inc. |
Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of radiation exposure
|
MA43348A
(fr)
|
2015-10-01 |
2018-08-08 |
Novo Nordisk As |
Conjugués de protéines
|
KR102147997B1
(ko)
*
|
2015-10-23 |
2020-08-25 |
주식회사 제넥신 |
피부 주름 개선용 조성물
|
ES2903257T3
(es)
|
2015-12-09 |
2022-03-31 |
Scripps Research Inst |
Proteínas de fusión de inmunoglobulina de relaxina y métodos de uso
|
WO2017117464A1
(en)
|
2015-12-30 |
2017-07-06 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
MX2018009800A
(es)
|
2016-02-12 |
2018-11-09 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista, usos de los mismos y procedimientos de identificacion de los mismos.
|
EP3442579A4
(de)
|
2016-04-15 |
2019-12-18 |
Immunext Inc. |
Anti-human-vista-antikörper und verwendung davon
|
EP3474884A4
(de)
|
2016-06-22 |
2020-08-19 |
Alkermes, Inc. |
Zusammensetzungen und verfahren zur modulierung von il-10-immunostimulatorischen und entzündungshemmenden eigenschaften
|
MX2019003445A
(es)
*
|
2016-09-27 |
2019-09-26 |
Epicentrx Inc |
Proteinas de fusion inmunomoduladoras.
|
KR20190094222A
(ko)
|
2016-12-13 |
2019-08-12 |
데리니아, 인크. |
다가 조절성 t 세포 조절제
|
CN110505885A
(zh)
|
2017-04-05 |
2019-11-26 |
诺和诺德股份有限公司 |
寡聚体延伸的胰岛素-Fc缀合物
|
EP3630162A1
(de)
*
|
2017-05-24 |
2020-04-08 |
Novartis AG |
Antikörper-zytokin-gepfropfte proteine und verfahren zur verwendung
|
EA202090838A1
(ru)
|
2017-09-27 |
2020-08-28 |
Эписентарикс, Инк. |
Иммуномодулирующие слитые белки
|
CN111989340A
(zh)
*
|
2018-11-18 |
2020-11-24 |
杭州博虎生物科技有限公司 |
一种重组人白细胞介素10融合蛋白及其应用
|
AU2020364071A1
(en)
|
2019-10-10 |
2022-05-26 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
WO2021146436A2
(en)
|
2020-01-14 |
2021-07-22 |
Synthekine, Inc. |
Biased il2 muteins methods and compositions
|